Genetic testing to predict sudden cardiac death: current perspectives and future goals

Area of Science:

• Cardiovascular Genetics
• Sudden Cardiac Death Etiology
• Molecular Cardiology

Background:

• Monogenic disorders like Long QT Syndrome, Brugada Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy are established causes of sudden cardiac death in the young.
• Historically, the genetic basis of sudden cardiac death was confined to these rare inherited conditions.
• Emerging clinical evidence indicates that sudden cardiac death risk may aggregate within families, suggesting a more widespread genetic contribution.

Purpose of the Study:

• To review current knowledge on the genetics of sudden cardiac death.
• To discuss the application of genetic testing for risk stratification and therapy selection in monogenic cardiac diseases.
• To explore the role of genetics in patient profiling for acquired cardiovascular diseases.

Main Methods:

• Literature review of genetic studies related to sudden cardiac death.
• Analysis of clinical data supporting familial clustering of sudden cardiac death.
• Discussion of genetic risk stratification and therapeutic strategies in monogenic disorders.
• Examination of genetic contributions to acquired cardiovascular diseases.

Main Results:

• Monogenic traits are significant predisposing factors for sudden death in young, healthy individuals.
• Clinical data increasingly support a genetic component in the broader spectrum of sudden cardiac death.
• Genetics plays a role in both inherited cardiomyopathies and acquired cardiovascular conditions.

Conclusions:

• Genetics is crucial for understanding and managing sudden cardiac death, from rare monogenic diseases to acquired conditions.
• Genetic insights are vital for accurate risk stratification and personalized therapy selection.
• Further research into the genetic architecture of sudden cardiac death is warranted.